Holding Structure in Guatemala: Manufacturer, Registration Holder and Importer Responsibilities
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The holding structure in Guatemala involves three parties: the foreign manufacturer (issuing the letter of authorisation and the manufacturing evidence), the registration holder (Titular) (which must be a distributor or wholesaler domiciled in the country holding a sanitary licence, NT 37 Article 5.1.13), and the importer (handling the import licence and customs clearance, NT 26 v3-2017). The responsibilities of the three parties are expressly allocated by the documentation items of Article 5 of NT 37, and among them the registration holder and the responsible professional also jointly bear the market withdrawal obligation when a test fails (Annex 2 note, within 15 days). The import stage adds a fourth function, handled under NT 26 v3-2017, which may sit with any of the three parties or with a separate logistics provider, depending on the commercial model. Because the obligations attach to named roles rather than to the product, the choice of who occupies each role is itself a compliance decision. A structure that looks convenient commercially can concentrate obligations on a party that cannot execute them, while a structure built deliberately keeps the regulatory duties and the commercial risks in separable lanes. The table below is the reference point for that design: it shows which role carries which obligation and under which article, so that the division of duties written into contracts matches what the authority will enforce.
2. Legal basis
The table below allocates the obligations across the roles in the holding structure. Each obligation is tied to a specific article of NT 37 or to the import standard, so the table can be used directly as the checklist when contracts and appointment documents are drafted.
| Foreign manufacturer | Issue the letter of authorisation (legalised copy); provide the free sale certificate; provide the certificate of good manufacturing practice or an equivalent sanitary standard; provide the quality control certificate | Articles 5.1.5, 5.1.6, 5.1.7, 5.1.9 |
| Registration holder | Provide a copy of the establishment sanitary licence; act as the recorded holder of the registration | Article 5.1.13, Article 6.1 |
| Responsible professional | Sign the application form and the change forms | Article 5.1.2, the change items of Article 6 |
| Legal representative | Issue the sworn declaration at renewal; appoint the responsible professional | Article 9.2, Article 6.8.3 |
| Registration holder + responsible professional | Jointly bear the 15-day market withdrawal obligation on test failure | Annex 2 note |
| Import stage | Import licence procedure | NT 26-2016, Versión 3-2017 (updated 2018-06-08) |
3. Expert insights
Insight 1: The registration holder and the importer can be the same entity, or they can be separated. NT 37 only requires the registration holder to hold an establishment sanitary licence (Article 5.1.13), and the import stage runs separately under the NT 26 procedure. Combining the two reduces coordination costs, but it exposes the registration to direct shock whenever the commercial channel changes. Separating them increases the volume of coordination, but it insulates the registration asset from channel risk. Neither choice is free; the decision should be made consciously, with the trade-off documented at the project initiation stage, and revisited whenever the distribution model changes materially.
Insight 2: The withdrawal obligation binds the registration holder and the responsible professional together. The Annex 2 note requires the “propietario y responsable” jointly to withdraw the product within 15 days. This means the registration holder is not a nominal certificate holder but a party bearing substantive legal consequences. When selecting the registration holder, its execution capability and willingness to cooperate should be assessed, precisely because the withdrawal duty cannot be performed by the manufacturer remotely. A holder without warehouse control, distribution visibility or staff to run a recall will convert a 15-day obligation into a failed one.
Insight 3: The manufacturer keeps control through the letter of authorisation. The letter of authorisation under Article 5.1.7 determines who can represent the manufacturer before the DRCPFA. Its scope should cover registration, changes and renewal, and a mechanism for re-issuance should be retained — this is the legal instrument through which the manufacturer preserves its initiative within the holding structure. An authorisation that is narrow or stale transfers practical control to the holder by default. For this reason the authorisation documents should be inventoried at the same cadence as the registrations themselves, with expiry dates tracked alongside the certificate dates.
Insight 4: Article 6.1 provides the exit for adjusting the structure. Change of holder is listed as the first category of change, requiring the legal documents, the original registration certificate, the original packaging and the payment receipt. The structure can be adjusted afterwards, but the cost and the cooperation requirements are not low, so it is best to get the structure right at the project initiation stage rather than relying on a later change. Where an adjustment proves unavoidable, the four documentation items should be collected before the filing is made, because an incomplete holder-change submission restarts the review rather than advancing it.
4. Practical recommendations
- Fix the three-party structure once at project initiation and record the division of duties in a written document.
- Keep the registration holder separate from the commercial channel wherever possible, so that channel changes do not strike the registration asset.
- Cover registration, changes and renewal in the letter of authorisation, and retain a mechanism for re-issuance.
- Assess the execution capability of the registration holder, particularly its ability to perform the market withdrawal obligation.
- Prepare the four documentation items for structural adjustment under Article 6.1, and reserve time for the procedure.
5. Verification checklist
- □ Division of duties among manufacturer, registration holder and importer fixed in writing
- □ Registration holder holds a valid establishment sanitary licence
- □ Scope of the letter of authorisation covers registration, changes and renewal
- □ Execution capability of the registration holder assessed
- □ Contingency plan for structural adjustment prepared under Article 6.1
- □ Import stage scheduled separately under NT 26 v3-2017
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us